New York City Mayor Zohran Mamdani (D) said Saturday that Democrats have lost sight of the important economic issues facing working-class Americans as the party works to rebuild itself after a devastating loss in the 2024 presidential election.
“The party, as a whole, has lost its focus on working people,” Mamdani said in an interview with MS Now.
“People want to know: What are you going to do for rent? What are you going to do for housing? What are you going to do for gas? What are you going to do for groceries? We have to have answers to that.”
Issues like housing affordability, the cost of healthcare and rising gas prices should be at the forefront of the party’s focus, according to Mamdani, rather than ideological battles that distract from what matters to most Americans.
What I mean when I say ‘it seems obvious to me’ is that based on the results of reputable scientific investigation it seems clear that trans women retain some degree of biological advantage over people born female.
Which studies? Done with what methodology? And what are the rebuttals against their claims? Did the study differentiate trans women who are not on HRT, newly on HRT, and on HRT past the several year adjustment period? Same question, for age at which HRT or puberty blockers began. And does the reported difference fall outside the expected range for feminine athletes? Did the study include a group of cis boys or cis men as contrast? Were trans boys and trans men also included to show the presumable equivalent disadvantage?
There have been some infamous studies recently done by transphobes and cited as evidence of their bigoted viewpoint. Science thankfully doesn’t itself care about politics and these studies will either be refuted or confirmed as more science is done.
And as I alluded to before, even if merely having been assigned male at birth gave some advantage in competitive sport, that advantage is entirely irrelevant to scholastic activities and only relevant to professional conpetitions if it puts trans women substantially outside the range of expected competitors.